Thyroid-hormone therapy and thyroid cancer: a reassessment (Q36575425)

15 August 2017

1 reference

title

Thyroid-hormone therapy and thyroid cancer: a reassessment (English)

1 reference

15 August 2017

1 reference

Bernadette Biondi

1

1 reference

PubMed ID

16929364

15 August 2017

Sebastiano Filetti

series ordinal

2

1 reference

PubMed ID

16929364

15 August 2017

Martin Schlumberger

series ordinal

3

1 reference

15 August 2017

1 November 2005

1 reference

Nature Clinical Practice Endocrinology and Metabolism

15 August 2017

1 reference

15 August 2017

1

1 reference

15 August 2017

1

1 reference

15 August 2017

32-40

1 reference

Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Conversion of Thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Levothyroxine therapy in patients with thyroid disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Metastatic carcinoma of the thyroid successfully treated with thyroxine

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Mitogenic effects of thyrotropin and adenosine 3',5'-monophosphate in differentiated normal human thyroid cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Presence of TSH receptor in thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Characterization of the Thyrotropin Receptor-Adenylate Cyclase System in Neoplastic Human Thyroid Tissue*

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Graves' disease, thyroid nodules and thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Epidermal growth factor modulates thyroid growth and function in culture

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT)

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Subclinical hyperthyroidism: clinical features and treatment options

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assay

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Joint statement on the U.S. Food and Drug Administration's decision regarding bioequivalence of levothyroxine sodium

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Increased need for thyroxine in women with hypothyroidism during estrogen therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Influence of triiodothyronine withdrawal time on 131I uptake postthyroidectomy for thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

The aging thyroid. The use of thyroid hormone in older persons

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Levothyroxine treatment and occurrence of fracture of the hip.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Risk for fracture in women with low serum levels of thyroid-stimulating hormone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Effects of subclinical thyroid dysfunction on the heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Evaluation, by noninvasive methods, of the effects of acute loss of thyroid hormones on the heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0020

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0020

1 reference

15 August 2017

1 reference

PubMed ID

16929364